(S)-(-)-Canadine

CAS: 5096-57-1

Ref. 3D-FAA09657

Produktinformation

• Name: (S)-(-)-Canadine
• Synonyme: (-)-Canadine, (-)-Tetrahydroberberine, (-)-α-Canadine, (13aS)-5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, (13aS)-9,10-dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline, (D,L)-Tetrahydroberberine, (S)-(-)-7,8,13,13a-Tetrahydroberberine, (S)-(-)-Tetrahydroberberine, (S)-9,10-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline, 13aα-Berbine, 9,10-dimethoxy-2,3-(methylenedioxy)-, 6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-, (13aS)-, 6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-, (S)-, 9,10-Dimethoxy-2,3-(methylenedioxy)-13aα-berbine, 9,10-dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline, O-Methyl Nandinine, l-Canadine

Beschreibung

Canadine is an alkaloid and the major active ingredient in the herbal medicine berberine. It has been used for the treatment of metabolic disorders, such as diabetes mellitus. Canadine can cause drug interactions with other drugs that are metabolized by cytochrome P450 enzymes and may increase oxidative injury to cells. Canadine has also shown efficacy against oral pathogens in animal models. Toxicological studies have been conducted on rats, showing that it may cause liver damage and energy metabolism disturbances. This drug has been found to be effective for treating some experimental models of liver disease such as chronic hepatitis or cirrhosis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 339.4 g/mol
• Formel: C₂₀H₂₁NO₄
• Reinheit: Min. 95%